Insight Molecular Diagnostics Inc
(IMDX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,623 | -16,840 | -7,732 | -22,426 | -14,472 |
| Depreciation Amortization | 1,627 | 522 | 298 | 447 | 336 |
| Income taxes - deferred | -1,095 | -1,095 | -1,095 | N/A | 0 |
| Accounts receivable | -372 | -85 | 8 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,843 | 1,064 | 1,247 | 741 | -416 |
| Other Working Capital | 936 | 194 | 340 | -1,555 | -2,754 |
| Other Operating Activity | 848 | 2,409 | 64 | 3,078 | 2,897 |
| Operating Cash Flow | $-19,836 | $-13,831 | $-6,870 | $-19,715 | $-14,409 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,061 | -535 | -44 | -918 | -18 |
| Net Acquisitions | -6,189 | -6,189 | -6,189 | N/A | N/A |
| Purchase Of Investment | -4,000 | -4,000 | N/A | -11,245 | -11,245 |
| Other Investing Activity | 0 | 0 | 42 | -252 | 64 |
| Investing Cash Flow | $-11,250 | $-10,724 | $-6,191 | $-12,415 | $-11,199 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,141 | 1,141 | N/A | -516 | N/A |
| Debt Repayment | -178 | -160 | -17 | -1,121 | -923 |
| Common Stock Issued | 18,415 | 18,342 | 7,597 | 46,505 | 41,193 |
| Common Stock Repurchased | -14 | -14 | -14 | N/A | N/A |
| Other Financing Activity | -58 | -31 | -1 | 3,000 | -3,252 |
| Financing Cash Flow | $19,306 | $19,278 | $7,565 | $47,868 | $37,018 |
| Beginning Cash Position | 23,772 | 23,772 | 23,773 | 8,034 | 8,034 |
| End Cash Position | 11,992 | 18,495 | 18,277 | 23,772 | 19,444 |
| Net Cash Flow | $-11,780 | $-5,277 | $-5,496 | $15,738 | $11,410 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,836 | -13,831 | -6,870 | -19,715 | -14,409 |
| Capital Expenditure | -1,061 | -535 | -44 | -918 | -18 |
| Free Cash Flow | -20,897 | -14,366 | -6,914 | -20,633 | -14,427 |